Pentobarbital will minimize the level or outcome of alfentanil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Slight/Importance Unknown. pentobarbital will reduce the extent or influence of suvorexant by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Watch. Strong CYP3A4 inducers could decrease suvorexant efficacy; if elevated suvorexant dose necessary... https://paulj567jao6.goabroadblog.com/profile